
Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1108 | 1108 | 1130 | 1471 | 2276 | 1869 |
Fund Return | 10.76% | 10.76% | 12.99% | 13.72% | 17.88% | 6.45% |
Place in category | 140 | 140 | 72 | 3 | 26 | 25 |
% in Category | 32 | 32 | 19 | 1 | 8 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Brandes International Small Cap EqI | 679.55M | 10.47 | 22.83 | 8.55 | ||
Brandes Emerging Markets Value I | 447.4M | 4.86 | 7.93 | 3.71 | ||
Brandes Emerging Markets Value A | 156.76M | 2.51 | 3.28 | 2.99 | ||
Brandes International Small Cap Equ | 93.92M | 3.68 | 18.04 | 8.46 | ||
Brandes International Equity Fund A | 77.2M | 4.23 | 8.64 | 6.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 40.34B | 9.68 | 7.60 | 4.90 | ||
Fidelity Series International VVV | 15.42B | 14.01 | 11.24 | 6.62 | ||
Causeway International Value Instl | 12.19B | 10.13 | 12.73 | 6.11 | ||
Vanguard International Value Inv | 12.28B | 4.58 | 4.54 | 4.65 | ||
DFA International Value I | 9.39B | 11.20 | 9.82 | 6.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Takeda Pharmaceutical | JP3463000004 | 3.03 | 4,190.0 | +0.72% | |
Alibaba | KYG017191142 | 2.69 | 105.40 | -4.09% | |
Heineken | NL0000008977 | 2.49 | 66.80 | +2.14% | |
GSK plc | GB00BN7SWP63 | 2.23 | 1,339.50 | -0.48% | |
Sanofi | FR0000120578 | 2.18 | 91.04 | -0.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | BUY | Strong Buy |
Summary | Neutral | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review